MARIA CAMPBELL: Open Payments
NPI 1548741465 · AMARILLO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$472 in 24 payments from 11 companies in 2025. Trend: 2023 $441 · 2024 $337 · 2025 $472
Food & beverage: $472
| Company | Payments | Amount |
|---|---|---|
| MAYNE PHARMA COMMERCIAL LLC | 7 | $119 |
| Astellas Pharma US Inc | 5 | $105 |
| Sumitomo Pharma America, Inc. | 3 | $63 |
| Organon LLC | 2 | $36 |
| PFIZER INC. | 1 | $28 |
| Vertex Pharmaceuticals Incorporated | 1 | $28 |
| Lundbeck LLC | 1 | $23 |
| Dexcom, Inc. | 1 | $22 |
| Daiichi Sankyo Inc. | 1 | $17 |
| Seqirus USA Inc | 1 | $15 |
Products named: Veozah, MYFEMBREE, NEXPLANON, ABRYSVO, JOURNAVX, VYEPTI, Dexcom G6 Transmitter, INJECTAFER.
Industry payments across TX — which companies pay providers there.
